autoimmune disease therapy (Guangzhou Wuzhou Zhongheng Group/Sichuan University)

N/A

Report date: 2025/06/11 10:52:12
NME

Base Information

Drug Nameautoimmune disease therapy (Guangzhou Wuzhou Zhongheng Group/Sichuan University)
Drug Alias Nameimmunosuppressive agent (Guangzhou Wuzhou Zhongheng Group/Sichuan University)SKLB-628SKLB-507
ClassificationSmall molecules
Mechanisms of ActionImmunosuppressants
TargetsUpdating
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSichuan University
China Registration ClassN/A

Develop Information

Active CompaniesGuangxi Wuzhou Zhongheng Group Co Ltd
Inactive CompaniesSichuan University
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A